Atigotatug + nivolumab + chemotherapy in first-line (1L) extensive-stage small cell lung cancer (ES-SCLC): extended follow-up from the phase 2 CA001-050 study (ESMO-IO 2026) - Oct 25, 2026 - Abstract #266P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical • P2 data • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
|
|
Kenneth J. O'Byrne; Idris Bahce; Alejandro F. Navarro Mendivil; Neal Ready; Quincy Siu-chung Chu; Shun ichi Sugawara; Anne Sibille; Mariano Provencio Pulla; Melissa L. Johnson; Jeroen T. Hiltermann; Tudo r-Eliade Ciuleanu; Rafal Dziadziuszko; Antonio Santo; Vishwanath Gharpure; Manoj Desai; Samira Soleymani; Christophe Cal vet; Steven I. Blum; Diederik Grootendorst; Ewa Kalinka
|